Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy.

PURPOSE To evaluate diffusion-weighted (DW)-MRI as a noninvasive tool to investigate major salivary gland function before and after radiotherapy (RT) for head and neck cancer (HNC). METHODS AND MATERIALS DW-MRI was performed in 8 HNC patients before and after parotid-sparing RT (mean dose to the contralateral parotid gland <26 Gy). A DW sequence was performed once at rest and then repeated continuously during salivary stimulation. Apparent diffusion coefficient (ADC) maps for both parotid and submandibular glands were calculated. Findings were compared with salivary gland scintigraphy. RESULTS Before RT, the mean ADC value at rest was significantly lower in the parotid than in the submandibular glands. During the first 5 min of stimulation, the ADC value of the salivary glands showed a decrease, followed by a steady increase until a peak ADC, significantly higher than the baseline value, was reached after a median of 17 min. The baseline ADC value at rest was significantly higher after RT than before RT in the nonspared salivary glands but not in the spared parotid glands. In the contralateral parotid glands, the same response was seen as before RT. This pattern was completely lost in the nonspared glands. These results corresponded with remaining or loss of salivary function, respectively, as confirmed by salivary gland scintigraphy. CONCLUSIONS Diffusion-weighted-MRI allows noninvasive evaluation of functional changes in the major salivary glands after RT and is a promising tool for investigating radiation-induced xerostomia.

[1]  D. Le Bihan Molecular diffusion, tissue microdynamics and microstructure. , 1995, NMR in biomedicine.

[2]  Avraham Eisbruch,et al.  Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[3]  R. Hermans,et al.  Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  J. Kronenberg,et al.  Salivary flow and its relation with oral symptoms in terminally ill patients , 2000, Cancer.

[5]  A R Padhani,et al.  Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. , 2006, The British journal of radiology.

[6]  T. Kurabayashi,et al.  Salivary glands and lesions: evaluation of apparent diffusion coefficients with split-echo diffusion-weighted MR imaging--initial results. , 2001, Radiology.

[7]  D. Brizel,et al.  How should we measure and report radiotherapy-induced xerostomia? , 2003, Seminars in radiation oncology.

[8]  R. Yoshimura,et al.  Functional evaluation with intravoxel incoherent motion echo‐planar MRI in irradiated salivary glands: A correlative study with salivary gland scintigraphy , 2001, Journal of magnetic resonance imaging : JMRI.

[9]  M. Martel,et al.  Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. , 1996, International journal of radiation oncology, biology, physics.

[10]  R. Hermans,et al.  Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer , 2007, Head & neck.

[11]  F. Hilgers,et al.  Scintigraphic assessment of salivary function and excretion response in radiation‐induced injury of the major salivary glands , 1994, Cancer.

[12]  J. Lagendijk,et al.  3D MR sialography protocol for postradiotherapy follow‐up of the salivary duct system , 2006, Journal of magnetic resonance imaging : JMRI.

[13]  Heikki Joensuu,et al.  Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[15]  P. Lambin,et al.  Preservation of parotid function with uncomplicated conformal radiotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Harm Meertens,et al.  Volume effects and region-dependent radiosensitivity of the parotid gland. , 2005, International journal of radiation oncology, biology, physics.

[17]  E. Glatstein Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management , 2008 .

[18]  A. Vissink,et al.  Radioprotective effect of amifostine on parotid gland functioning is region dependent. , 2005, International journal of radiation oncology, biology, physics.

[19]  F. De Keyzer,et al.  Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. , 2006, The British journal of radiology.

[20]  P. Lambin,et al.  The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy , 2001, Nuclear medicine communications.

[21]  S. Sunaert,et al.  Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. , 2005, Radiology.

[22]  Sandra Nuyts,et al.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.

[23]  P. D. Dios,et al.  Whole stimulated salivary flow in patients with chronic hepatitis C virus infection. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  J. Lagendijk,et al.  3D MR sialography as a tool to investigate radiation-induced xerostomia: feasibility study. , 2007, International journal of radiation oncology, biology, physics.

[25]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  K. Hayashi,et al.  Diffusion-weighted echoplanar MR imaging of the salivary glands. , 2002, AJR. American journal of roentgenology.

[27]  A. Garden,et al.  Intensity-modulated radiotherapy: Is xerostomia still prevalent? , 2005, Current oncology reports.

[28]  C. Terhaard,et al.  Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[29]  C. Boesch,et al.  Diffusion‐weighted imaging of the parotid gland: Influence of the choice of b‐values on the apparent diffusion coefficient value , 2004, Journal of magnetic resonance imaging : JMRI.

[30]  C. Terhaard,et al.  A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. , 2005, International journal of radiation oncology, biology, physics.

[31]  Sandra Nuyts,et al.  Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.

[32]  S. Nill,et al.  Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. , 2004, International journal of radiation oncology, biology, physics.

[33]  P. Lambin,et al.  Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.